Therapeutic effect of yoga in patients with hypertension with reference to GST gene polymorphism

Journal of Alternative and Complementary Medicine

Volumn 19, Issue 3, 2013, Pages 243-249

  Dhameja, Kanupriya ^a   Singh, Savita ^a   Mustafa, M D ^a   Singh, K P ^a   Banerjee, Basu Dev ^a   Agarwal, Mukul ^a   Ahmed, Rafat S ^a  

^a UNIVERSITY COLLEGE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE T1; IRON; MALONALDEHYDE;

ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; CASE CONTROL STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MULTIPLEX POLYMERASE CHAIN REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL; THERAPY EFFECT; YOGA;

ADULT; ANTIOXIDANTS; BLOOD PRESSURE; GLUTATHIONE TRANSFERASE; HUMANS; HYPERTENSION; MALONDIALDEHYDE; MEDITATION; MIDDLE AGED; OXIDATIVE STRESS; POLYMORPHISM, GENETIC; YOGA;

EID: 84875436016     PISSN: 10755535     EISSN: 15577708     Source Type: Journal    
DOI: 10.1089/acm.2011.0908     Document Type: Article

References (40)

1. Todkar SS, Gujarathi VV, Tapare VS. Period prevalence and sociodemographic factors of hypertension in rural Maharashtra: A cross-sectional study. Indian J Community Med 2009;34:183-187.
2. Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC VII report. JAMA 2003;289:2560-2572.
3. Vaziri ND, Wang XQ, Oveisi F, Rad B. Induction of oxidative stress by glutathione depletion causes severe hypertension in normal rats. Hypertension 2000;36:142-146.
4. Kashyap M, Yadav V, Sherawat B, et al. Different antioxidants status, total antioxidant power and free radicals in essential hypertension. Mol Cell Biochem 2005;277: 89-99.
5. Hayes JD, Flanagan JU, Jowsey IR. Glutathione transferases. Annu Rev Pharmacol Toxicol 2005;45:51-88.
6. Hayes JD, Pulford DJ. The glutathione S-transferase supergene family: Regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit Rev Biochem Mol Biol 1995;30:445-600.
7. Mishra DK, Kumar A, Srivastava DS, Mittal RD. Allelic variation of GSTT1, GSTM1 and GSTP1 genes in North Indian population. Asian Pac J Cancer Prev 2004;5:362-365.
8. Pemble S, Schroeder KR, Spencer SR, et al. Human glutathione S-transferase theta (GSTT1): cDNA cloning and the characterization of a genetic polymorphism. Biochem J 1994; 15:271-276.
9. Schiffrin EL, Touyz RM. From bedside to bench to bedside: Role of the renin-angiotensin-aldosterone system in remodeling of resistance arteries in hypertension. Am J Physiol Heart Circ Physiol 2004;287:H435-H446.
10. McBride MW, Brosnan MJ, Mathers J, et al. Reduction of Gstm1 expression in the stroke-prone spontaneously hypertension rat contributes to increased oxidative stress. Hypertension 2005;45:786-792.
11. Mustafa M, Pathak R, Ahmed T, et al. Association of glutathione S-transferase M1 and T1 gene polymorphisms and oxidative stress markers in preterm labor. Clin Biochem 2010;43:1124-1128.
12. Kumar V, Yadav CS, Datta SK, et al. Association of GSTM1 and GSTT1 polymorphism with lipid peroxidation in benign prostate hyperplasia and prostate cancer: a pilot study. Dis Markers 2011;30:163-169.
13. Brown RP, Gerbarg PL. Sudarshan Kriya yogic breathing in the treatment of stress, anxiety, and depression: Part I-neurophysiologic model. J Altern Complement Med 2005; 11:189-201.
14. Wallace RK. Physiological effects of Transcendental Meditation. Science 1970;167:1751-1754.
15. Sharma H, Sen S, Singh A, et al. Sudarshan Kriya practitioners exhibit better antioxidant status and lower blood lactate levels. Biol Psychol 2003;63:281-291.
16. Yadav RK, Ray RB, Vempati R, Bijlani RL. Effect of a comprehensive yoga based lifestyle modification program on lipid peroxidation. Indian J Physiol Pharmacol 2005;49:358-362.
17. Bhattacharya S, Pandey US, Verma NS. Improvement in oxidative status with yogic breathing in young healthy males. Indian J Physiol Pharmacol 2002;46:349-354.
18. Satoh K. Serum lipid peroxide in cerebrovascular disorders determine by a new colorimetric method. Clin Chim Acta 1978;90:37-43.
19. Benzie IF, Strain JJ. Ferric reducing/antioxidant power assay: Direct measure of total antioxidant activity of biological fluids and modified version for simultaneous measurement for total antioxidant power and ascorbic acid concentration. Methods Enzymol 1999;299:15-27.
20. Habig WH, Pabst MJ, Jakoby WB. Glutathione S-transferases: The first step in mercapturic acid formation. J Biol Chem 1974;249:7130-7139.
21. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265-275.
22. Sahay BK. Yoga and meditation. Med Update 1999;9:26-28.
23. Divekar M, Bhat M, Mulla A. Effect of yoga therapy in diabetes and obesity. J Diabet Assoc India 1978;17:75-78.
24. Barnes VA, Treiber FA, Davis H. Impact of Transcendental Meditation on cardiovascular function at rest and during acute stress in adolescents with high normal blood pressure. J Psychosom Res 2001;51:597-605.
25. Cowen VS, Adams TB. Physical and perceptual benefits of yoga asana practice: Results of a pilot study. J Bodyw Mov Ther 2005;9:211-219.
26. Schneider RH, Nidich SI, Salerno JW, et al. Lower lipid peroxide levels in practitioners of the TM program. Psychosom Med 1998;60:38-41.
27. Martarelli D, Cocchioni M, Scuri S, Pompei P. Diaphragmatic breathing reduces exercise-induced oxidative stress. Evidence Based Complement Altern Med 2011;Feb 10:e-pub ahead of prin.t.
28. Bessa SS, Ali EM, Hamdy SM. The role of glutathione S-transferase M1 and T1 gene polymorphisms and oxidative stress-related parameters in Egyptian patients with essential hypertension. Eur J Intern Med 2009;20:625-630.
29. Griendling KK, Sorescu D, Lassegue B, Ushio-Fukai M. Modulation of protein kinase activity and gene expression by reactive oxygen species and their role in vascular physiology and pathophysiology. Arterioscler Thromb Vasc Biol 2000;20:2175-2183.
30. Dominiczak AF, Negrin DC, Clark JS, et al. Genes and hypertension: From gene mapping in experimental models to vascular gene transfer strategies. Hypertension 2000;35: 164-172.
31. Oniki K, Hori M, Takata K, et al. Association between glutathione S-transferase A1, M1 and T1 polymorphisms and hypertension. Pharmacogenet Genom 2008;18:275-277.
32. Capoluongo E, Onder G, Concolino P, et al. GSTM1-null polymorphism as possible risk marker for hypertension: Results from the aging and longevity study in the Sirente Geographic Area (iISIRENTE study). Clin Chim Acta 2009;399:92-96.
33. Saadat M, Dadbine-Pour A. Influence of polymorphism of glutathione S-transferase M1 on systolic blood pressure of normotensive individuals. Biochem Biophys Res Commun 2005;326:449-454.
34. Tew MB, Reveille JD, Arnett FC, et al. Glutathione S-transferase genotypes in systemic sclerosis and their association with clinical manifestations in early disease. Genes Immun 2001;2:236-238.
35. Amin JK, Xiao L, Pimental DR, et al. Reactive oxygen species mediate alpha-adrenergic receptor stimulated hypertrophy in adult rat ventricular myocytes. J Mol Cell Cardiol 2001;33:131-139.
36. Fu YC, Chi CS, Yin SC, et al. Norepinephrine induces apoptosis in neonatal rat cardiomyocytes through a reactive oxygen species-TNF alpha-caspase signaling pathway. Cardiovasc Res 2004;62:558-567.
37. Raju PS, Anil Kumar K, Reddy SS, et al. Effect of yoga on exercise tolerance in normal healthy volunteers. Indian J Physiol Pharmacol 1986;30:121-132.
38. Sinha S, Singh SN, Monga YP, Ray US. Improvement of glutathione and total antioxidant status with yoga. J Altern Complement Med 2007;13:1085-1090.
39. Dumont A, Hehner SP, Hofmann TG, et al. Hydrogen peroxide-induced apoptosis is CD95-independent, requires the release of mitochondria-derived reactive oxygen species and the activation of NF-kappaB. Oncogene 1999;18: 747-757.
40. Bradley AA, Nathan CF. Glutathione metabolism as a determinant of therapeutic efficiency. Cancer Res 1984;44: 4224-4232.